USA India Chamber of commerce

Chair and Master of Ceremonies (Emcee) - Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals
16th annual BioPharma & Healthcare Summit

Virtual Summit
Date: Friday, June 24, 2022
Time: 8 AM EST to 3:30 PM EST (Eastern Standard Time)

*Speaker and Timings subject to change

Time	Topic
8:00 AM - 8:10 AM	Welcome address: Karun Rishi, President, USAIC Opening comments: Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals
8:10 AM - 8:55 AM	Moving Closer to Cure for More Cancer Patients Panelists: Dr. Christine Ward, Vice President, Head of Oncology and Cell Therapy, Takeda Pharmaceuticals Dr. Eric Rubin, Senior Vice President, Therapeutic Area Head Oncology, Early Development, Merck Research Labs Dr. Samarth Kulkarni, Chief Executive Officer, CRISPR Therapeutics Dr. Sam Waksal, Chairman and Chief Executive Officer, Equilibre Biopharmaceuticals Dr. Todd Golub, Director and Founding Core Member, Broad Institute of MIT & Harvard Moderator: Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic
8:55 AM - 9:00 AM	Polling + Break
9:00 AM - 9:40 AM	Fireside Chat Alex Gorsky, Executive Chairman, Johnson & Johnson Moderator: Christopher Viehbacher, Founding Partner, Gurnet Point Capital
9:40 AM - 9:45 AM	Polling + Break
9:45 AM - 10:30 AM	Clinical Trials Landscape in India Panelists: Dr. Cynthia Verst, President, Design & Delivery Innovation for Research and Development Solutions, IQVIA Dr. Kush Parmar, Managing Partner, 5AM Ventures Dr. Naresh Trehan, Chairman, Medanta Peter Ronco, Head of Global Development, Janssen Research and Development, Johnson & Johnson Dr. Vinod Paul, Member, National Institution for Transforming India, the NITI Aayog Moderator: Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals
10:30 AM - 10:35 AM	Polling + Break
10:35 AM - 11:20 AM	Digital & Data Science Panel Panelists: Daphne Zohar, Founder & Chief Executive Officer, PureTech Health Dr. Karen Akinsanya, President of Research and Development, Therapeutics, Schrodinger Dr. Regina Barzilay, Professor of AI and Health, Massachusetts Institute of Technology Sastry Chilukuri, Co-Chief Executive Officer, Medidata Dr. Vipin Gopal, Chief Data & Analytics Officer, Eli Lilly Moderator: Chris Benko, Co-Founder and Chief Executive Officer, Koneksa Health
11:20 AM - 11:25 AM	Polling + Break
11:25 AM - 12:10 PM	Pandemics: Where does the world go from here Panelists: Dr. Larry Tabak, Acting Director, National Institutes of Health (NIH) Dr. John Mascola, Chief Scientific Officer, ModeX Therapeutics Dr. Julie Gerberding, Chief Executive Officer, Foundation for the NIH (FNIH) Kiran Mazumdar-Shaw, Executive Chairperson, Biocon Moderator: Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University
12:10 PM - 12:20 PM	Polling + Break
12:20 PM - 1:05 PM	Industry & Investment Outlook Panel Panelists: Christopher Viehbacher, Founding Partner, Gurnet Point Capital Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group Rajiv Kaul, Portfolio Manager, Fidelity Investments Dr. Stelios Papadopoulos, Chairman of the Board, Biogen Moderator: Jennifer Fox, Chief Financial Officer, Nuvation Bio
1:05 PM - 1:10 PM	Polling + Break
1:10 PM - 1:55 PM	Rethinking Rare: Resolutions for reinvention in a genomic age Panelists: Dr. Alfred Sandrock, Chief Executive Officer, Voyager Therapeutics Charlene Son Rigby, Chief Executive Officer, RARE-X Paula Soteropoulos, Chairman of the Board, Ensoma Dr. Philip Larsen, Global Head of Research, Bayer Pharma Max Bronstein, Assistant Director for Health Innovation, White House Office of Science & Technology Policy Moderator: Dr. Timothy Yu, Associate Professor in Pediatrics, Harvard Medical School
1:55 PM - 2:00 PM	Polling + Break
2:00 PM - 2:50 PM	Research and Development Strategies & Trends Panel Panelists: Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals Dr. David Reese, Executive Vice President, Research and Development, Amgen Dr. John Reed, Global Head of Research and Development, Sanofi Dr. Mathai Mammen, Executive Vice President, Pharmaceuticals, Research and Development, Johnson & Johnson Moderator: Dr. Martin Mackay, Co-Founder, Rallybio
2:50 PM - 3:20 PM	Closing Remarks and Wrap Up Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals Advisory Board Members and Speakers